EXHIBIT 1

AGREEMENT

The persons below hereby agree that the Schedule 13G to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13G, shall be filed on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(l)(iii) under the Securities Exchange Act of 1934.

Date: February 14, 2022

PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. By: PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P. Its General Partner, By: PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD. Its General Partner,
By:	/s/ Robert Hopfner
	Robert Hopfner Authorized Signatory
PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P. By: PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD Its General Partner,
By:	/s/ Robert Hopfner
	Robert Hopfner Authorized Signatory
PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD.
By:	/s/ Robert Hopfner
	Robert Hopfner Authorized Signatory
PIVOTAL PARTNERS LTD
By:	/s/ Sun Xintong
Name:	Sun Xintong
Title:	Director
PIVOTAL LIFE SCIENCES HOLDINGS LIMITED
By:	/s/ Sun Xintong
Name:	Sun Xintong
Title:	Director

NAN FUNG GROUP HOLDINGS LIMITED
By:	/s/ Tang Chun Wai Nelson
	Tang Chun Wai Nelson Director
By:	/s/ Cheung Vincent Sai Sing
	Cheung Vincent Sai Sing Director
NF INVESTMENT HOLDINGS LIMITED
By:	/s/ Tang Chun Wai Nelson
	Tang Chun Wai Nelson Director
NAN FUNG LIFE SCIENCES HOLDINGS LIMITED
By:	/s/ Sun Xintong
	Sun Xintong Director
NFLS BETA LIMITED
By:	/s/ Sun Xintong
	Sun Xintong Director
NFLS PLATFORM HOLDINGS LIMITED
By:	/s/ Sun Xintong
	Sun Xintong Director